These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18805646)

  • 1. Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception.
    Wallach JV
    Med Hypotheses; 2009 Jan; 72(1):91-4. PubMed ID: 18805646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.
    Jacob MS; Presti DE
    Med Hypotheses; 2005; 64(5):930-7. PubMed ID: 15780487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators.
    Berry MD
    J Neurochem; 2004 Jul; 90(2):257-71. PubMed ID: 15228583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.
    Strassman RJ; Qualls CR; Berg LM
    Biol Psychiatry; 1996 May; 39(9):784-95. PubMed ID: 8731519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMT at fifty.
    Szára S
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):201-5. PubMed ID: 18510265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogens.
    Nichols DE
    Pharmacol Ther; 2004 Feb; 101(2):131-81. PubMed ID: 14761703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain.
    Burchett SA; Hicks TP
    Prog Neurobiol; 2006 Aug; 79(5-6):223-46. PubMed ID: 16962229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.
    Frecska E; Szabo A; Winkelman MJ; Luna LE; McKenna DJ
    J Neural Transm (Vienna); 2013 Sep; 120(9):1295-303. PubMed ID: 23619992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trace amine-associated receptors are olfactory receptors in vertebrates.
    Liberles SD
    Ann N Y Acad Sci; 2009 Jul; 1170():168-72. PubMed ID: 19686131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.
    Su TP; Hayashi T; Vaupel DB
    Sci Signal; 2009 Mar; 2(61):pe12. PubMed ID: 19278957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans.
    Barman R; Kumar Bora P; Saikia J; Konwar P; Sarkar A; Kemprai P; Proteem Saikia S; Haldar S; Slater A; Banik D
    Phytochemistry; 2024 Feb; 218():113928. PubMed ID: 38035973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.
    Klein LM; Cozzi NV; Daley PF; Brandt SD; Halberstadt AL
    Neuropharmacology; 2018 Nov; 142():231-239. PubMed ID: 29499272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered consciousness states and endogenous psychoses: a common molecular pathway?
    Ciprian-Ollivier J; Cetkovich-Bakmas MG
    Schizophr Res; 1997 Dec; 28(2-3):257-65. PubMed ID: 9468359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.
    Kometer M; Vollenweider FX
    Curr Top Behav Neurosci; 2018; 36():257-282. PubMed ID: 27900674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Resurgence of Hallucinogen Drugs in Clinical Research.
    Rivera-García MT; Cruz SL
    Rev Invest Clin; 2023; 75(3):169-178. PubMed ID: 37441761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enlightening the "Spirit Molecule": Photomodulation of the 5-HT
    Gerwe H; He F; Pottie E; Stove C; Decker M
    Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202203034. PubMed ID: 35349196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Hallucinogenic Serotonin-2A Receptor Agonist Reduces Visual Response Gain and Alters Temporal Dynamics in Mouse V1.
    Michaiel AM; Parker PRL; Niell CM
    Cell Rep; 2019 Mar; 26(13):3475-3483.e4. PubMed ID: 30917304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid effects of tryptamine psychedelics on perceptual distortions and early visual cortical population receptive fields.
    Pais ML; Teixeira M; Soares C; Lima G; Rijo P; Cabral C; Castelo-Branco M
    Neuroimage; 2024 Aug; 297():120718. PubMed ID: 38964563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.